Absci Takes Its Generative AI Antibody Design Platform To Europe

Generative AI technology, like ChatGPT, is disrupting many industriesincluding biopharma. For example, Absci is using AI to design & validate de novo antibodies. And now Absci is expanding itsoperation to Europe to disrupt the protein-based therapeutics market.